Skip to main content

Table 1 Demographic information of participants whose serum samples were collected

From: Expression levels of MCP-1, HGF, and IGF-1 in endometriotic patients compared with non-endometriotic controls

Characteristic

Endometriosis (n = 70)

Control (n = 70)

Pvalue

Age (years)

32.7 ± 5.33 †

32.1 ± 6.98

0.569

BMI (kg/m2)

24.3 ± 3.7

25.7 ± 5.45

0.069

Marital status, n (%)

 Single

18 (25.71)

17 (24.28)

0.845

 Married

52 (74.28)

53 (75.71)

 

Infertility among married, n (%)

18 (34.61)

12 (22.64)

0.174

Cycle phase, n (%)

 Secretory

29 (41.43)

32 (45.71)

0.609

 Proliferative

41 (58.57)

38 (54.28)

 

Stage, n (%)

 I & II

22 (31.42)

  

 III & IV

48 (68.57)

  

Endometriosis type, n (%)

 Ovarian endometriosis (pure)

3 (4.29)

  

 Peritoneal endometriosis (pure)

8 (11.43)

  

 Tubo-ovarian & peritoneal endometriosis (including DIE)

59 (84.28)

  
  1. †Data are mean ± SD
  2. Comparison was performed with Student’s t-test, or χ2- test, as appropriate
  3. Abbreviations: BMI: Body mass index; DIE: Deep infiltrating endometriosis; n: Number